Critique of Hue et al.:
XMRV proteins have been detected in prostate cancer patients (Schlaberg et al 2009). These authors demonstrated that IHC increased detection rates by 400% compared to PCR.
Arnold et al (2010) demonstrated the presence of antibodies to XMRV using FISH serology in prostate cancer patients who were otherwise healthy. Arnold and others also demonstrated that FISH improved detection rates by over 400% compared to PCR.